Scientific Name(s): Ganoderma lucidum (Leysser ex Fr.) Karst. Family: Polyporaceae.
Common Name(s): Reishi , ling chih , lingzhi ( ling zhi ), “ spirit plant ,” Ganopoly
The polysaccharide content of reishi mushroom is responsible for possible anticancer and immunostimulatory effects. Reishi may also provide hepatoprotective action, antiviral activity, and beneficial effect on the cardiovascular system, rheumatoid arthritis, chronic fatigue syndrome, and diabetes. Few clinical trials have been conducted.
The Pharmacopoeia of the People's Republic of China recommends 6 to 12 g reishi extract daily. Ganopoly (a Ganoderma lucidum polysaccharide extract) in doses up to 5.4 g daily (equivalent to 81 g of the fruiting body) for 12 weeks has been used in a few clinical trials.
Contraindications have not been identified.
Information regarding safety and efficacy in pregnancy and lactation is lacking.
None well documented.
Adverse reactions are mild and may include dizziness, GI upset, and skin irritation.
There are few reports of toxicity with the use of reishi mushroom.
The reishi mushroom is a purplish-brown fungus with a long stalk, brown spores, and a fan-shaped cap with a shiny, varnish-coated appearance. Reishi grows on decaying wood or tree stumps, 1 preferring the Japanese plum tree but also found on oak. The mushroom is native to China, Japan, and North America but is cultivated throughout other Asian countries. Cultivation of reishi is a long, complicated process. The reishi grows in 6 colors, each thought to have different characteristics and known as: Aoshiba (blue reishi), Akashiba (red reishi), Kishiba (yellow reishi), Shiroshiba (white reishi), Kuroshiba (black reishi), and Murasakishiba (purple reishi). 2 , 3
Reishi has been used in traditional Chinese medicine for more than 4,000 years for treating fatigue, asthma, cough, and liver ailments, and to promote longevity. 2 The Chinese name lingzhi means “herb of spiritual potency.” 2 A Japanese name for the reishi is mannentake , meaning “10,000-year-old mushroom.” Reishi's use is documented in the oldest Chinese medical text, which is more than 2,000 years old. 4 Cultivation of reishi began in the 1980s. A survey conducted in Hong Kong found G. lucidum to be the third most common herbal preparation taken by preoperative surgical patients. 5
The reishi mushroom is high in polysaccharide content with at least 36 different compounds identified, 6 including beta-d-glucan and GL-1. 2 , 3 , 7 Triterpene constituents also have been analyzed. 8 Triterpene antioxidants, including ganoderic acids A, B, C, and D; ganoderol A and B; ganoderol A; lucidenic acid B, and ganodermanontriol have been found in reishi. 1 , 2 , 6 , 9 , 10 , 11 Terpenoids 1, 2, and 3, and terpenes lucidenic acid O and lucidenic lactone are also present. 3 , 6 , 12 A peptidoglycan from reishi contained approximately 7% protein and 76% carbohydrate. 13 Certain enzymes from reishi have been reported, 14 as well as minerals such as calcium, magnesium, and potassium. Lanostan, coumarins, ergosterol, and cerevisterol are also components of reishi. 2 , 3 , 12
Uses and PharmacologyCancer
Anticancer effects of reishi have been reported largely from in vivo experiments, and data from clinical trials have been published. It is generally accepted that the anticancer effects are due to immune enhancement 3 , 15 and may be exhibited from diverse chemical constituents in reishi. 6 , 16 , 17 Experiments focused on the stimulatory effects of the higher molecular weight polysaccharides (eg, ganopoly, beta-d-glucan, GL-1) on the immune system, 3 , 7 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 and the suppressive effect of the triterpenes (eg, ganoderic acid) on the growth and invasive behavior of cancer cells. 15 , 16 , 18 , 30 , 31 , 32 , 33 , 34 An ethanol soluble compound ganoderol B binds to androgen receptors and inhibits the sterol enzyme 5-alpha-reductase in experiments in rats. 1Clinical data
Clinical trials have been conducted in patients with advanced cancer. 15 , 16 , 35 Not all published trials are randomized and blinded. Ganopoly in doses up to 5.4 g daily (equivalent to 81 g of the fruiting body) for 12 weeks were used. Increased cellular immunity indices were reported in 80% of cancer patients in one trial. 36 Quality of life improved in 65% of patients in another trial. 16 In a further trial, varying results were obtained. It was proposed that ganopoly could reverse the immunosuppressive effects of chemotherapy and radiotherapy. 36 , 37
In a case report of the effect of lingzhi on gastric large B-cell lymphoma, the patient consumed 3 times the recommended dose for 5 days (60 capsules daily). Histological changes were recorded 11 days later, showing only a dense infiltrate of T lymphocytes remaining. 38Cardiovascular effects
The effect of reishi on the cardiovascular system has been investigated. Decreases in high blood pressure were reported to be attributed to the ganoderic acids. 2 Angiotensin-converting enzyme-inhibiting triterpenes from reishi have been described. 3 , 39 Inhibition of cholesterol biosynthesis, enhanced antioxidase activity, decreased platelet aggregation, 2 , 3 , 40 and reduced lipid peroxidation have been demonstrated in animal and in vitro experiments. 2 , 3 , 10Diabetes
In animal experiments, ganopoly affected carbohydrate metabolism and promoted insulin secretion. In a clinical trial of patients with type 2 diabetes, ganopoly 1,800 mg 3 times daily reduced postprandial glucose values. The glucans ganoderan A and B (glucans) inhibited hypoglycemia in clinical studies. 3Hepatitis
In in vitro and in vivo animal experiments, hepatoprotection by extracts of ganoderma against induced liver damage has been demonstrated. 3 , 26 , 41 , 42 , 43 Polysaccharide ganopoly therapy for 6 months resulted in normalization of aminotransferase levels in 33% and cleared serum hepatitis B surface antigen in 13% of trial participants compared with control. 3Rheumatoid Arthritis
The effect of reishi on the immune system has been studied in in vitro experiments. In an experiment using synovial fluid from patients with rheumatoid arthritis, researchers demonstrated an inhibitory effect of a polysaccharide extract on the proliferation of synovial fibroblasts, possibly via the nuclear factor-kappa B transcription pathway. 44 Two clinical trials have been conducted involving patients with rheumatoid arthritis. Both trials used a combination of lingzhi plus San-Miao-San, therefore making it difficult to attribute the positive outcomes to the individual agents. 5 , 45Other effects
Polysaccharides isolated from reishi have been proven effective in vitro against herpes simplex virus types 1 and 2. 46 Reishi isolates also have been tested against other viral strains, including influenza A, and demonstrated effectiveness against their replication. 47Chronic fatigue syndrome
A multicenter, double-blind, randomized, placebo-controlled trial was conducted in China. Ganopoly 5.4 g daily was administered for 8 weeks, resulting in a reduced sense of fatigue and lower Clinical Global Impression severity scores. 31
Traditional practitioners recommend 0.5 to 1 g daily, 2 to 5 g daily for chronic illness, and up to G. lucidum 15 g extract daily for serious illness. 5 The Chinese pharmacopoeia recommends 6 to 12 g extract daily. 5 Doses up to Ganopoly 5.4 g daily (equivalent to 81 g of the fruiting body) for 12 weeks have been used in clinical trials. 35
Information regarding safety and efficacy in pregnancy and lactation is lacking.
None well documented.
In a small, placebo-controlled trial designed to determine adverse reactions related to reishi use, 4 g of extract daily for 10 days taken by healthy adults resulted in no differences between participants receiving reishi and those taking placebo. 48 No changes in blood CD4, CD8, or CD19 were observed, and insignificant increases in CD56 were noted. 48
Ganodermic acid S and adenosine-related compounds found in reishi are thought to cause platelet inhibition, and a protease compound has been demonstrated to competitively inhibit thrombin-fibrinogen binding in in vitro experiments. However, another placebo-controlled trial using 1.5 g of extract daily for 4 weeks did not result in any changes in platelet or hemostatic function. 49
Research reveals little information regarding toxicity with the use of reishi mushroom. A mean lethal dose has been estimated to be 10 to 21 g per kg body weight. Animal experiments have tested dosages up to 38 g/kg. 5
Bibliography1. Liu J , Shimizu K , Konishi F , Kumamoto S , Kondo R . The anti-androgen effect of ganoderol B isolated from the fruiting body of Ganoderma lucidum . Bioorg Med Chem . 2007 ; 15 ( 14 ): 4966-4972 .
2. Lininger SW, Wright JV, et al, eds. The Natural Pharmacy . Rocklin, CA: Prima Publishing; 1998:303-304.
3. Zhou X , Lin J , Yin Y , Zhao J , Sun X , Tang K . Ganodermataceae: natural products and their related pharmacological functions . Am J Chin Med . 2007 ; 35 ( 4 ): 559-574 .
4. Matsumoto K . The Mysterious Reishi Mushroom . Santa Barbara, CA: Woodbridge Press Publishing; 1979 .
5. Li EK , Tam LS , Wong CK , et al. Safety and efficacy of Ganoderma lucidum (lingzhi) and San Miao San supplementation in patients with rheumatoid arthritis: a double-blind, randomized, placebo-controlled pilot trial . Arthritis Rheum . 2007; 57 ( 7 ): 1143-1150 .
6. Paterson RR . Ganoderma—a therapeutic fungal biofactory . Phytochemistry . 2006 ; 67 ( 18 ): 1985-2001 .
7. Miyazaki T , Nishijima M . Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum . Chem Pharm Bull . 1981 ; 29 ( 12 ): 3611-3616 .
8. Kohda H , Tokumoto W , Sakamoto K , et al. The biologically active constituents of Ganoderma lucidum (Fr.) Karst. Histamine release-inhibitory triterpenes . Chem Pharm Bull (Tokyo). 1985 ; 33 ( 4 ): 1367-1374 .
9. Zhu M , Chang Q , Wong LK , Chong FS , Li RC . Triterpene antioxidants from Ganoderma lucidum . Phytother Res . 1999 ; 13 ( 6 ): 529-531 .
10. Hajjaj H , Macé C , Roberts M , Niederberger P , Fay LB . Effect of 26-oxygenosterols from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors . Appl Environ Microbiol . 2005 ; 71 ( 7 ): 3653-3658 .
11. Tang W , Liu JW , Zhao WM , Wei DZ , Zhong JJ . Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells . Life Sci . 2006 ; 80 ( 3 ): 205-211 .
12. Mizushina Y , Takahashi N , Hanashima L , et al. Lucidenic acid O and lactone, new terpene inhibitors of eukaryotic DNA polymerases from a basidiomycete, Ganoderma lucidum . Bioorg Med Chem . 1999 ; 7 ( 9 ): 2047-2052 .
13. Cheong J , Jung W , Park W . Characterization of an alkali-extracted peptidoglycan from Korean Ganoderma lucidum . Arch Pharm Res . 1999 ; 22 ( 5 ): 515-519 .
14. D'Souza TM , Merritt CS , Reddy CA . Lignin-modifying enzymes of the white rot basidiomycete Ganoderma lucidum . Appl Environ Microbiol . 1999 ; 65 ( 12 ): 5307-5313 .
15. Lin ZB , Zhang HN . Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharmacol Sin . 2004 ; 25 ( 11 ): 1387-1395 .
16. Yuen JW , Gohel MD . Anticancer effects of Ganoderma lucidum : a review of scientific evidence . Nutr Cancer . 2005 ; 53 ( 1 ): 11-17 .
17. Kuo MC , Weng CY , Ha CL , Wu MJ . Ganoderma lucidum mycelia enhance innate immunity by activating NF-kappaB . J Ethnopharmacol . 2006 ; 103 ( 2 ): 217-222 .
18. Müller CI , Kumagai T , O'Kelly J , Seeram NP , Heber D , Koeffler HP . Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells . Leuk Res . 2006 ; 30 ( 7 ): 841-848 .
19. Sliva D . Ganoderma lucidum in cancer research . Leuk Res . 2006 ; 30 ( 7 ): 767-768 .
20. Kim HS , Kacew S , Lee BM . In vitro chemopreventive effects of plant polysaccharides ( Aloe barbadensis miller , Lentinus edodes , Ganoderma lucidum and Coriolus versicolor ) . Carcinogenesis . 1999 ; 20 ( 8 ): 1637-1640 .
21. Gao Y , Gao H , Chan E , et al. Antitumor activity and underlying mechanisms of ganopoly, the refined polysaccharides extracted from Ganoderma lucidum , in mice . Immunol Invest . 2005 ; 34 ( 2 ): 171-198 .
22. Pang X , Chen Z , Gao X , et al. Potential of a novel polysaccharide preparation (GLPP) from Anhui-grown Ganoderma lucidum in tumor treatment and immunostimulation . J Food Sci . 2007 ; 72 ( 6 ): S435-S442 .
23. Zhu XL , Lin ZB . Effects of Ganoderma lucidum polysaccharides on proliferation and cytotoxicity of cytokine-induced killer cells . Acta Pharmacol Sin . 2005 ; 26 ( 9 ): 1130-1137 .
24. Lin YL , Lee SS , Hou SM , Chiang BL . Polysaccharide purified from Ganoderma lucidum induces gene expression changes in human dendritic cells and promotes T helper 1 immune response in BALB/c mice . Mol Pharmacol . 2006 ; 70 ( 2 ): 637-644 .
25. Lin YL , Liang YC , Lee SS , Chiang BL . Polysaccharide purified from Ganoderma lucidum induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and p38 mitogen-activated protein kinase pathways . J Leukoc Biol . 2005 ; 78 ( 2 ): 533-543 .
26. Li YQ , Wang SF . Anti-hepatitis B activities of ganoderic acid from Ganoderma lucidum . Biotechnol Lett . 2006 ; 28 ( 11 ): 837-841 .
27. Lin KI , Kao YY , Kuo HK , et al. Reishi polysaccharides induce immunoglobulin production through the TLR4/TLR2-mediated induction of transcription factor Blimp-1 . J Biol Chem . 2006 ; 281 ( 34 ): 24111-24123 .
28. Chan WK , Lam DT , Law HK , et al. Ganoderma lucidum mycelium and spore extracts as natural adjuvants for immunotherapy . J Altern Complement Med . 2005 ; 11 ( 6 ): 1047-1057 .
29. Lin ZB . Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum . J Pharmacol Sci . 2005 ; 99 ( 2 ): 144-153 .
30. Yue GG , Fung KP , Tse GM , Leung PC , Lau CB . Comparative studies of various ganoderma species and their different parts with regard to their antitumor and immunomodulating activities in vitro . J Altern Complement Med . 2006 ; 12 ( 8 ): 777-789 .
31. Tang W , Gao Y , Chen G , et al. A randomized, double-blind and placebo-controlled study of a Ganoderma lucidum polysaccharide extract in neurasthenia . J Med Food . 2005 ; 8 ( 1 ): 53-58 .
32. Cao QZ , Lin ZB . Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell . Life Sci . 2006 ; 78 ( 13 ): 1457-1463 .
33. Stanley G , Harvey K , Slivova V , Jiang J , Sliva D . Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells . Biochem Biophys Res Commun . 2005 ; 330 ( 1 ): 46-52 .
34. Kim KC , Kim JS , Son JK , Kim IG . Enhanced induction of mitochondrial damage and apoptosis in human leukemia HL-60 cells by the Ganoderma lucidum and Duchesnea chrysantha extracts . Cancer Lett . 2007 ; 246 ( 1-2 ): 210-217 .
35. Gao Y , Tang W , Dai X , et al. Effects of water-soluble Ganoderma lucidum polysaccharides on the immune functions of patients with advanced lung cancer . J Med Food . 2005 ; 8 ( 2 ): 159-168 .
36. Gao Y , Zhou S , Jiang W , Huang M , Dai X . Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients . Immunol Invest . 2003 ; 32 ( 3 ): 201-215 .
37. Kim KC , Kim IG . Ganoderma lucidum extract protects DNA from strand breakage caused by hydroxyl radical and UV irradiation . Int J Mol Med . 1999 ; 4 ( 3 ): 273-277 .
38. Cheuk W , Chan JK , Nuovo G , Chan MK , Fok M . Regression of gastric large B-Cell lymphoma accompanied by a florid lymphoma-like T-cell reaction: immunomodulatory effect of Ganoderma lucidum (Lingzhi)? Int J Surg Pathol . 2007 ; 15 ( 2 ): 180-186 .
39. Morigiwa A , Kitabatake K , Fujimoto Y , Ikekawa N . Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum . Chem Pharm Bull (Tokyo) . 1986 ; 34 ( 7 ): 3025-3028 .
40. Su CY , Shiao MS , Wang CT . Differential effects of ganodermic acid S on the thromboxane A2-signaling pathways in human platelets . Biochem Pharmacol . 1999 ; 58 ( 4 ): 587-595 .
41. Wang S , et al. The role of Ganoderma lucidum in immunopotentiation: Effect on cytokine release from human macrophages and T-lymphocytes. In: Program and Abstracts of the 1994 International Symposium on Ganoderm Research . Beijing: Beijing Medical University.
42. Chang H-M, But P, eds. Pharmacology and Applications of Chinese Materia Medica . Vol. 1. Singapore: World Scientific; 1986.
43. Byun S , Rim IH . Studies on the concurrent administration of Ganoderma lucidum extract and glutathione on liver damage induced by carbon tetrachloride in rats . J Pharm . 1987 ; 31 : 133-139 .
44. Ho YW , Yeung JS , Chiu PK , et al. Ganoderma lucidum polysaccharide peptide reduced the production of proinflammatory cytokines in activated rheumatoid synovial fibroblast . Mol Cell Biochem . 2007 ; 301 ( 1-2 ): 173-179 .
45. Xi Bao Y , Kwok Wong C , Kwok Ming Li E , et al. Immunomodulatory effects of lingzhi and san-miao-san supplementation on patients with rheumatoid arthritis . Immunopharmacol Immunotoxicol . 2006 ; 28 ( 2 ): 197-200 .
46. Eo SK , Kim YS , Lee CK , Han SS . Antiherpetic activities of various protein bound polysaccharides isolated from Ganoderma lucidum . J Ethnopharmacol . 1999 ; 68 ( 1-3 ): 175-181 .
47. Eo SK , Kim YS , Lee CK , Han SS . Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum . J Ethnopharmacol . 1999 ; 68 ( 1-3 ): 129-136 .
48. Wicks SM , Tong R , Wang CZ , et al. Safety and tolerability of Ganoderma lucidum in healthy subjects: a double-blind randomized placebo-controlled trial . Am J Chin Med . 2007 ; 35 ( 3 ): 407-414 .
49. Kwok Y , Ng KF , Li CC , Lam CC , Man RY . A prospective, randomized, double-blind, placebo-controlled study of the platelet and global hemostatic effects of Ganoderma lucidum (Ling-Zhi) in healthy volunteers . Anesth Analg . 2005 ; 101 ( 2 ): 423-426 .
Copyright © 2009 Wolters Kluwer Health